🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BenQ Medical Technology Corporation (TPEX:4116)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.55
-2.20 (-5.40%)
Nov 20, 2026, 1:24 PM CST

BenQ Medical Technology Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,3995,2544,7674,5434,3771,465
Revenue Growth
3.85%10.21%4.94%3.80%198.82%4.55%
Cost of Revenue
3,6473,5643,3193,1993,129952.31
Gross Profit
1,7521,6901,4481,3441,247512.28
Selling, General & Admin
1,4431,3091,079947.17855.13423.58
Research & Development
33.2534.6936.3931.9639.5839.65
Other Operating Expenses
----1.530.730.81
Operating Expenses
1,4781,3471,115978.46896.88465.82
Operating Income
273.46342.42333.02365.44350.2646.46
Interest Expense
-44.41-44.04-34.22-27.94-17.83-3.91
Interest & Investment Income
14.4612.7511.2310.215.240.69
Earnings From Equity Investments
----57.38-125.051.79
Currency Exchange Gain (Loss)
-22.6-22.68.98-2.53.44-0.53
Other Non Operating Income (Expenses)
809.2919.9710.9117.1514.2816.56
EBT Excluding Unusual Items
1,030308.5329.91304.98230.3361.06
Gain (Loss) on Sale of Investments
8.88.8-5.13--
Gain (Loss) on Sale of Assets
17.2517.25-0.9-0.033.850.06
Other Unusual Items
0.030.030.370.0981.570.66
Pretax Income
1,056334.58329.38310.17315.7461.78
Income Tax Expense
126.1116.9692.13109.9179.1512.75
Earnings From Continuing Operations
930.17217.62237.25200.26236.649.04
Minority Interest in Earnings
-169.4-139.45-132.42-85.68-56.35-20.2
Net Income
760.7678.17104.83114.58180.2428.84
Net Income to Common
760.7678.17104.83114.58180.2428.84
Net Income Growth
786.75%-25.43%-8.51%-36.43%524.98%-53.52%
Shares Outstanding (Basic)
454545454545
Shares Outstanding (Diluted)
464545454545
Shares Change
2.84%-0.10%0.02%-0.07%0.42%-0.30%
EPS (Basic)
17.021.752.352.574.040.65
EPS (Diluted)
16.511.752.342.564.020.65
EPS Growth
759.84%-25.21%-8.59%-36.32%521.20%-53.44%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
382.67264.8452.14308.88405.9591.09
Free Cash Flow Per Share
8.305.911.166.899.052.04
Dividend Per Share
2.0002.0001.6502.0002.1000.500
Dividend Growth
21.21%21.21%-17.50%-4.76%320.00%-50.00%
Gross Margin
32.45%32.16%30.38%29.58%28.50%34.98%
Operating Margin
5.07%6.52%6.98%8.04%8.00%3.17%
Profit Margin
14.09%1.49%2.20%2.52%4.12%1.97%
Free Cash Flow Margin
7.09%5.04%1.09%6.80%9.28%6.22%
EBITDA
435.64519.68509.07532.15520.51107.71
EBITDA Margin
8.07%9.89%10.68%11.71%11.89%7.36%
D&A For EBITDA
162.19177.26176.05166.72170.2461.25
EBIT
273.46342.42333.02365.44350.2646.46
EBIT Margin
5.07%6.52%6.98%8.04%8.00%3.17%
Effective Tax Rate
11.94%34.96%27.97%35.43%25.07%20.63%